(Total Views: 334)
Posted On: 03/02/2020 12:15:58 PM
Post# of 145254
Heads, I think you are correct in your assessment of Patient #3 no longer meeting the Trial parameter and therefore having to be dropped from the Study. It would be wonderful if she could receive Leronlimab via compassionate use protocol.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)